# An In Vivo Model for Postinflammatory Hyperpigmentation

> **NCT02905903** · NA · COMPLETED · sponsor: **Henry Ford Health System** · enrollment: 30 (actual)

## Conditions studied

- Post-inflammatory Hyperpigmentation

## Interventions

- **DRUG:** Tricholoacetic Acid (TCA)

## Key facts

- **NCT ID:** NCT02905903
- **Lead sponsor:** Henry Ford Health System
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-14
- **Primary completion:** 2018-05-16
- **Final completion:** 2019-06-21
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02905903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02905903, "An In Vivo Model for Postinflammatory Hyperpigmentation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02905903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*